# Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study

> **NCT01537315** · PHASE2 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 8 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Cardiovascular Disease
- Arteriosclerosis

## Interventions

- **DRUG:** Hydroxychloroquine
- **OTHER:** Matching Placebo

## Key facts

- **NCT ID:** NCT01537315
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2014-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01537315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01537315, "Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01537315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*